Big Pharma Is Investing Billions In AI— And The Value Is Finally Starting To Show

The last two years have witnessed explosive growth in the implementation of artificial intelligence for big healthcare organizations as well as large pharmaceutical companies. Initially, these investments were approached with pause, purely because the value proposition for AI use cases was still unclear. However, over time, as the technology stack has improved significantly and more emphasis has been placed on developing…